Prophylactic Ranibizumab for Exudative AMD in Vulnerable Eyes With Nonexudative AMD Trial (PREVENT) A Prospective Controlled Clinical Trial

Related

• 

  Expert Panel: AI

  Mark S. Humayun, MD, PhD

  Devinder S Chauhan, MD FRCOphth FRANZCO

  Ursula M. Schmidt-Erfurth, MD

  Jennifer I. Lim, MD, FARVO, FASRS

  Royce WS Chen, MD

  Annual Meeting Talks

  2024

• 

  Parameters Affecting Postoperative Success of Surgery for Stage 4a/4b ROP

  Sengul Ozdek, MD, FEBO, FASRS

  Annual Meeting Talks

  2018

• 

  3-Year Update for the Phase 3 Voretigene Neparvovec-rzyl Study in Biallelic RPE65 Mutation-Associated Inherited Retinal Disease

  Stephen R. Russell, MD

  Annual Meeting Talks

  2018